Business
BNB Plus Corp. (BNBX) Receives $1.2M Accelerated LineaDNA™ Order
Acceleration of Multi-Year Customer Agreement Represents Largest LineaDNA Order in Company History Company Expects to Ship over $1.5M of LineaDNA in 1HCY2026
About this update from Bnb Plus Corp.
[{"type":"text","content":"\nAcceleration of Multi-Year Customer Agreement Represents Largest LineaDNA Order in Company History\n\n\nCompany Expects to Ship over $1.5M of LineaDNA in 1HCY2026\n\n\n NEW YORK--(BUSINESS WIRE)--\nBNB Plus Corp. (Nasdaq: BNBX) (“BNBX” or the “Company”), today announced that it has received a $1.2M USD order for LineaDNA, representing the largest LineaDNA order in Company history. The order is an acceleration of an existing customer's annual purchasing cadence, consolidating what was originally planned as a two-year order cycle into an accelerated delivery schedule expected to be completed by May 2026.\n\n\nThe order was placed by a global manufacturer of in vitro diagnostics (IVDs) under an existing supply agreement. The Company has previously announced LineaDNA purchases by this customer, including a $600,000 USD follow-on order in July 2025. This latest order reflects the customer's decision to accelerate their procurement timeline, resulting in planned delivery within five months rather than the typical two-year cycle.\n\n\nInclusive of its recent $1.2M USD order, the Company expects to ship over $1.5M USD of LineaDNA to customers in the IVD and biotherapeutic markets in the first half of calendar year 2026.\n\n\nToday's announcement builds on the Company’s continued execution in its fulfillment of large LineaDNA orders. The Company recently announced it successfully manufactured and shipped a significant LineaDNA order valued at over $390,000 USD.\n\n\nAbout the LineaDNA Platform\n\n\nThe LineaDNA platform is a proprietary, cell-free DNA production system leveraging the Company’s deep expertise in large-scale PCR being commercialized by the Company’s LineaRx, Inc. subsidiary. Unlike conventional plasmid-based DNA production methods, the LineaDNA platform produces high-fidelity DNA that is free of adventitious sequences, rapidly scalable, and readily amenable to chemical modification. It can generate DNA from 100 base pairs to 20 kilobases in quantities from milligrams to grams under RUO, GLP, and GMP quality grades.\n\n\nAbout BNB Plus Corp.\n\n\nBNB Plus unlocks streamlined access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company’s differentiated strategy blends sophisticated DeFi...